Cook social media site to educate on ED

Share this article:
MensHealthPD.com
MensHealthPD.com
In an effort to educate physicians and consumers about a complex and painful form of erectile dysfunction know as Peyronie's disease, device manufacturer Cook Medical recently launched an unbranded physician education focused website found online at MensHealthPD.com.

The social networking microsite was designed to provide the most current information on Peyronie's, offering professionals and their patients public forums for discussing the disease.

“We are starting to think about how the future readers of medical news will gather their information,” said SVP and global strategic business unit leader for Cook Urology, Jerry French. “When I talk to urologists now, these people are getting their information online. One of the hallmarks for Cook has always been education, especially on the physician side,” French said. “Peyronie's is an issue that not a lot of people know about. We figured this would be a good opportunity for us to test the water on social media.”

Cook Medical is the maker of Surgisis Biodesign, a technology used for the replacement and repair of damaged human tissue in surgery. Surgisis Biodesign is used in various procedures, including Peyronie's repair. Surgisis Biodesign is derived from the small intestine of pigs and communicates with the body by signaling surrounding tissue to grow.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.

Shire, AbbVie join forces for $55B

Shire, AbbVie join forces for $55B

The deal includes a $1.6-billion fee if AbbVie tries to walk away.

Next target for hep. C drugmakers: co-infections

Next target for hep. C drugmakers: co-infections

An international AIDS conference this weekend kicked off a new battle in the war against hepatitis C: demonstrating high cure rates in those who are co-infected.